A Case Report on Methotrexate Overdose Induced Pancytopenia and Toxic Epidermal Necrolysis

Author(s)	Rahul Nikhumbe, Aniket Agarkar
Country	India
Abstract	Methotrexate is commonly used for autoimmune diseases including rheumatoid arthritis, psoriasis, sarcoidosis, and eczema due to its anti-inflammatory and immunosuppressive effect. The following report describes the case of a 48-year-old female presenting with complaints of fever, erythematous rash and blister over upper limb and oral hemorrhagic mucositis. She was previously diagnosed with rheumatoid arthritis and left sided poliomyelitis and was on methotrexate 15 mg weekly, but the patient had taken it daily resulting in toxicity. she was hospitalized, treated with folic acid, injection leucovorin & inj. filgrastim. Our case highlights the importance of counselling to ensure adherence to the correct methotrexate treatment regimen to prevent toxicity and its side effect.
Keywords	methotrexate, rheumatoid arthritis, pancytopenia, mucositis, toxic epidermal necrolysis
Field	Medical / Pharmacy
Published In	Volume 6, Issue 5, September-October 2024
Published On	2024-10-12
Cite This	A Case Report on Methotrexate Overdose Induced Pancytopenia and Toxic Epidermal Necrolysis - Rahul Nikhumbe, Aniket Agarkar - IJFMR Volume 6, Issue 5, September-October 2024. DOI 10.36948/ijfmr.2024.v06i05.28567
DOI	https://doi.org/10.36948/ijfmr.2024.v06i05.28567
Short DOI	https://doi.org/g7942j

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9898-5948-55	editor@ijfmr.com

International Journal For Multidisciplinary Research